Corrigendum to "Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo" [Vaccine: X 9 (2021) 100127].

Cheng, Alvan; Frey, Kurt; Mwamba, Guillaume Ngoie; McCarthy, Kevin A; Hoff, Nicole A; Rimoin, Anne W

Cheng, Alvan; Frey, Kurt; Mwamba, Guillaume Ngoie; McCarthy, Kevin A; Hoff, Nicole A; Rimoin, Anne W.

Afiliación

Cheng A; Department of Epidemiology, University of California, Los Angeles, CA, USA.
Frey K; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Mwamba GN; VillageReach, Ngaliema, Kinshasa, The Democratic Republic of the Congo.
McCarthy KA; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Hoff NA; Department of Epidemiology, University of California, Los Angeles, CA, USA.
Rimoin AW; Department of Epidemiology, University of California, Los Angeles, CA, USA.

Vaccine X ; 12: 100215, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36148264

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.1016/j.jvacx.2021.100127.].

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccine X Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google